美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Latigo Biotherapeutics Inc

22.29

-0.0800-0.36%

成交量：7.87万

成交额：179.31万

市值：14.10亿

市盈率：-1.13

高：25.00

开：22.62

低：22.00

收：22.37

52周最高：25.00

52周最低：17.22

股本：6,323.80万

流通股本：3,023.14万

量比：0.53

换手率：0.26%

股息：- -

股息率：- -

每股收益(TTM):-19.7441

每股收益(LYR):-20.1159

净资产收益率：--

总资产收益率：--

市净率：-5.58

市盈率(LYR):-1.11

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Latigo Biotherapeutics Inc

交易所：

NASDAQ

成立时间：

2018

员工人数：

- -

公司地址：

1300 Rancho Conejo Boulevard,Suite 305,Thousand Oaks,California,United States

官网：

http://www.latigobio.com

邮编：

91320

电话：

传真：

- -

简介：

Latigo Biotherapeutics, Inc.于2018年11月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于开发创新的非阿片类镇痛药物，旨在抑制疼痛传播而不会产生成瘾风险。其管道主要集中在Nav1.8抑制剂，初步开发努力针对肌肉骨骼疼痛。该公司还计划探索涉及疼痛传递的其他离子通道靶点，以建立最广泛的疼痛疗法管道之一。

董事

名称

职位

Nima Farzan

Chief Executive Officer and Director and President

Timothy P. Walbert

Chairman of the Board and Director

Beth Seidenberg

Director

Deborah Palestrant

Director

James B. Tananbaum

Director

Kevin Raidy

Director

Sara Bonstein

Director

Todd N. Smith

Director

股东

名称

职位

Nima Farzan

Chief Executive Officer and Director and President

Neha Krishnamohan

Chief Business Officer and Chief Financial Officer

Neil Singla

Chief Medical Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/LTGO/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LTGO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","market":"US","secType":"STK","nameCN":"Latigo Biotherapeutics Inc","latestPrice":22.29,"timestamp":1787597826710,"preClose":22.37,"halted":0,"volume":78701,"delay":0,"changeRate":-0.0035762181493071902,"floatShares":30231431,"shares":63238000,"eps":-19.74407,"marketStatus":"交易中","change":-0.08,"latestTime":"08-24 14:58:08 EDT","open":22.62,"high":25,"low":22,"amount":1793121.537774,"amplitude":0.134108,"askPrice":22.5,"askSize":190,"bidPrice":22,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-19.74407,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1786075200000,"exchange":"NASDAQ","adjPreClose":22.37,"preHourTrading":{"tag":"盘前","latestPrice":22.7,"preClose":22.37,"latestTime":"09:27 EDT","volume":2,"amount":45.370002,"timestamp":1787578020045,"change":0.33,"changeRate":0.014752,"amplitude":0.001341},"postHourTrading":{"tag":"盘后","latestPrice":22.7,"preClose":22.37,"latestTime":"19:30 EDT","volume":1274,"amount":28918.44,"timestamp":1787355008159,"change":0.33,"changeRate":0.014752,"amplitude":0.014752},"volumeRatio":0.528463},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LTGO\",,,,,undefined,":{"symbol":"LTGO","floatShares":30231431,"roa":"--","roe":"--","lyrEps":-20.11587,"volumeRatio":0.528463,"shares":63238000,"dividePrice":0,"high":25,"amplitude":0.134108,"preClose":22.37,"low":22,"week52Low":17.2201,"pbRate":"-5.58","week52High":25,"institutionHeld":0,"latestPrice":22.29,"committee":-0.310345,"eps":-19.74407,"divideRate":0,"volume":78701,"delay":0,"ttmEps":-19.74407,"open":22.62,"prevYearClose":18,"prevWeekClose":22.37,"prevMonthClose":18,"prevQuarterClose":18,"fiveDayClose":19.3,"twentyDayClose":18,"sixtyDayClose":18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LTGO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LTGO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LTGO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LTGO","date":"2026-08-21","current":-1.132998,"percent":0,"low":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"high":-10.257227,"avg":-11.062207,"sd":0.589939,"marketCap":1353293842},"quantilePoints":[{"date":"2026-08-07","current":-10.257227,"twenty":-10.257227,"median":-10.257227,"eighty":-10.257227,"marketCap":1140357438},{"date":"2026-08-14","current":-11.41033,"twenty":-11.020695,"median":-10.545739,"eighty":-10.380784,"marketCap":1268554881},{"date":"2026-08-21","current":-12.172536,"twenty":-11.41033,"median":-11.020695,"eighty":-10.534363,"marketCap":1353293842}],"updateTime":1787562713757},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":672821642,"yearFounded":2018,"address":"1300 Rancho Conejo Boulevard,Suite 305,Thousand Oaks,California,United States","zipCode":"91320","officePhone":"805 716 2927","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.latigobio.com","stockEarnings":[{"period":"1week","weight":0.1478},{"period":"1month","weight":0.2428},{"period":"ytd","weight":0.2428}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Latigo Biotherapeutics, Inc.于2018年11月在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，致力于开发创新的非阿片类镇痛药物，旨在抑制疼痛传播而不会产生成瘾风险。其管道主要集中在Nav1.8抑制剂，初步开发努力针对肌肉骨骼疼痛。该公司还计划探索涉及疼痛传递的其他离子通道靶点，以建立最广泛的疼痛疗法管道之一。","exchange":"NASDAQ","name":"Latigo Biotherapeutics Inc","nameEN":"Latigo Biotherapeutics Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LTGO\",market:\"US\",,,undefined,":{"directors":[{"name":"Nima Farzan","position":"Chief Executive Officer and Director and President"},{"name":"Timothy P. Walbert","position":"Chairman of the Board and Director"},{"name":"Beth Seidenberg","position":"Director"},{"name":"Deborah Palestrant","position":"Director"},{"name":"James B. Tananbaum","position":"Director"},{"name":"Kevin Raidy","position":"Director"},{"name":"Sara Bonstein","position":"Director"},{"name":"Todd N. Smith","position":"Director"}],"executives":[{"name":"Nima Farzan","position":"Chief Executive Officer and Director and President"},{"name":"Neha Krishnamohan","position":"Chief Business Officer and Chief Financial Officer"},{"name":"Neil Singla","position":"Chief Medical Officer"}]}}}